Literature DB >> 2837650

Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3.

A Thornell1, B Hallberg, T Grundström.   

Abstract

An electrophoretic mobility shift assay was used to characterize interactions of nuclear proteins with a DNA segment in the enhancer element of the leukemogenic murine retrovirus SL3-3. Mutation of a DNA sequence of the 5'-TGTGG-3' type decreased transcription in vivo specifically in T-lymphocyte cell lines. Extracts of nuclei from different T-lymphocyte cell lines or cells from lymphoid organs resulted in much higher amounts of complexes in vitro with this DNA sequence than did extracts from other cell lines or organs tested. Differences were also found in the sets of complexes obtained with extracts from the different types of cells. The DNA sequence specificities of the different SL3-3 enhancer factor 1 (SEF1) protein complexes were found to be distinct from those of several other previously identified DNA motifs of the TGTGG type because of differences in several nucleotides critical for binding and because these other DNA motifs could not compete with the identified DNA sequence for binding of SEF1. Limited treatment with several different proteases cleaved the SEF1 proteins such that their DNA-binding domain(s) remained and created complexes with decreased and nondistinguishable electrophoretic mobility shifts and with new properties. These results indicate that the SEF1 proteins have a structure with a flexible and relatively vulnerable hinge region linking a DNA-binding domain(s) to a more variable domain(s) with other functions. We suggest that the binding of SEF1 is an essential factor for the T-cell tropism of SL3-3 and the ability of this virus to cause T-cell lymphomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2837650      PMCID: PMC363322          DOI: 10.1128/mcb.8.4.1625-1637.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  74 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein.

Authors:  L Keegan; G Gill; M Ptashne
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

3.  Specific protein binding to the simian virus 40 enhancer in vitro.

Authors:  A G Wildeman; M Zenke; C Schatz; M Wintzerith; T Grundström; H Matthes; K Takahashi; P Chambon
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Fine mapping of an immunoglobulin gene activator.

Authors:  C Queen; J Stafford
Journal:  Mol Cell Biol       Date:  1984-06       Impact factor: 4.272

5.  Novel leukaemogenic retroviruses isolated from cell line derived from spontaneous AKR tumour.

Authors:  F S Pedersen; R L Crowther; D Y Tenney; A M Reimold; W A Haseltine
Journal:  Nature       Date:  1981-07-09       Impact factor: 49.962

Review 6.  Cyclic AMP receptor protein: role in transcription activation.

Authors:  B de Crombrugghe; S Busby; H Buc
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

7.  Contacts between Escherichia coli RNA polymerase and an early promoter of phage T7.

Authors:  U Siebenlist; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter.

Authors:  R W Carthew; L A Chodosh; P A Sharp
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

9.  Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts.

Authors:  I Davidson; C Fromental; P Augereau; A Wildeman; M Zenke; P Chambon
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

10.  Hybrid cell line from a cloned immunoglobulin-producing mouse myeloma and a nonproducing mouse lymphoma.

Authors:  B Mohit; K Fan
Journal:  Science       Date:  1971-01-08       Impact factor: 47.728

View more
  66 in total

1.  Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.

Authors:  M J Martiney; K Rulli; R Beaty; L S Levy; J Lenz
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.

Authors:  F K Yoshimura; T Wang; M Cankovic
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Regulation of c-Rel nuclear localization by binding of Ca2+/calmodulin.

Authors:  Asa Antonsson; Kate Hughes; Sofia Edin; Thomas Grundström
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.

Authors:  J C Tupper; H Chen; E F Hays; G C Bristol; F K Yoshimura
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Different relative expression from two murine leukemia virus long terminal repeats in unintegrated transfected DNA and in integrated retroviral vector proviruses.

Authors:  K Paludan; H Y Dai; M Duch; P Jørgensen; N O Kjeldgaard; F S Pedersen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

6.  PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.

Authors:  I Nuchprayoon; S Meyers; L M Scott; J Suzow; S Hiebert; A D Friedman
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.

Authors:  A C Massey; S C Lawrenz-Smith; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.

Authors:  A L Zaiman; A F Lewis; B E Crute; N A Speck; J Lenz
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.

Authors:  S Wang; Q Wang; B E Crute; I N Melnikova; S R Keller; N A Speck
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

10.  Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.

Authors:  M Plumb; R Fulton; L Breimer; M Stewart; K Willison; J C Neil
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.